Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial.

P. Poortmans,L. Collette,J. Horiot,W. van den Bogaert,A. Fourquet,A. Kuten,E. Noordijk,W. Hoogenraad,R. Mirimanoff,M. Piérart,E. van Limbergen,H. Bartelink
DOI: https://doi.org/10.1016/j.radonc.2008.07.011
IF: 6.901
Radiotherapy and Oncology
Abstract:
What problem does this paper attempt to address?